Cellares Launches Cell Q, the World’s First Automated cGMP QC Workcell for Cell Therapies, to Resolve Manual QC Processing Bottleneck and Extend IDMO Capabilities from Manufacturing Through Quality Control
The series B round positions T-knife to start assessing whether its mouse platform can bring the benefits of cell therapies to solid tumors.
aribou Biosciences, a Phase 1 biotech developing gene edited cell therapies for multiple cancers, announced terms for its IPO on Monday.
Bayer-backed Senti Biosciences, advancing off-the-shelf CAR-NK cell therapies, is taking control of its manufacturing destiny at a new in-house plant.
Will work together to deliver CAR-T Cell therapies to patients at point-of-care.
Standardized and automated manufacturing aims to reduce the amount of work on producing CAR-T cells by 50 percent.
Two years after the executive team at BrainStorm Cell Therapeutics decided to back off a controversial attempt to sell their stem cell therapy for ALS under the new ‘Right to Try’ legislation, the biotech is back with the top-line data from Phase III. And the data aren’t good.